PLX094440

GSE109228: Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinsons disease patient neurons and MPTP treated mice

• Organsim human
• Type RNASEQ
• Target gene
• Project ARCHS4

Dysfunctions in mitochondria dynamics and metabolism are common pathological processes associated with Parkinsons disease (PD). Recently, it was shown that an inherited form of PD and dementia is caused by new mutations in the OPA1 gene, which encodes for a key player of mitochondrial fusion and structure. iPSC-derived neural cells from these patients exhibited severe mitochondrial fragmentation, respiration impairment, ATP deficits and heightened oxidative stress. Reconstitution of normal levels of OPA1 in PD-derived neural cells normalized mitochondria morphology and function. OPA1 mutated neuronal cultures showed reduced survival in vitro. Intriguingly, selective inhibition of necroptosis effectively rescued this survival deficit. Additionally, dampening necroptosis in MPTP treated mice protected from DA neuronal cell loss. This human iPSC-based model captures both the early pathological events in OPA1 mutant neural cells and the beneficial effects of blocking necroptosis, highlighting this cell death process as a promising therapeutic target for PD. SOURCE: Luca Massimino (admin@lucamassimino.com) - Stem Cells and Neurogenesis Ospedale San Raffaele